Re: Farmas USA
Re: Farmas USA
Yo humildemente pienso igual, no hay correlación alguna entre el indice y las acciones. Puede que a medida que avance la sesión tiendas a ajustar precios, de lo contrario sería una subida no sana.
Comprar o no comprar, siempre un dilema.
Re: Farmas USA
Re: Farmas USA
Que lejos estan esos 400, aunque nunca se sabé, las tendencias pueden cambiar.
Re: Farmas USA
Trump y el sector, por el Bastardo
"Trump is unlikely to focus much on drug pricing and unlikely to really reform any Medicare particularly w/ GOP Congress against this," wrote RBC biotech analyst Michael Yee in a Wednesday research note.
He added: "More fundamentally to biotech -- the key is the rest of the election results i.e. Congress staying Republican (so less interest in drug pricing bills or reforming Medicare) and Prop 61 is not looking to pass these are actually nearly a 'best case' scenario for biotech."
Almost 80% of healthcare investors believe major drug-pricing reform is off the table